International Leader in the Field of Regenerative Dietary Supplement
Since 1987
Our Company
MEBO Life Science Inc. is a division of MEBO International Group, which was established in 1987 and is an international leader in the field of regenerative supplements.
Our primary mission is to help people regain and maintain optimal health and well-being by innovating and producing quality products in the exciting and promising field of regenerative medicine. MEBO holds a number of patents for innovative scientific formulations that are based on natural organic herbs that support, enhance and unleash the body’s own regenerative abilities so that the body can begin the astounding process of healing itself.
Patrons and practitioners that have used our products and experienced the restoration of the body’s natural regenerative abilities become our best customers and word-of-mouth advocates.
Our Founder
Dr. Rongxiang Xu is the founder of MEBO International.
Dr. Xu's pursuit of regenerative medicine started when he was a medical student at Medical College of Qingdao University in China in the early 1980's. Trained as a surgeon and general practice physician, he was assigned to treat severely burned patients during his residency. Having witnessed the horrific pain and scarring of burn patients treated with conventional burns therapy, Dr. Xu was determined to discover a more effective, less painful therapy.
Instead of following the conventional treatment procedures that require keeping burn wounds dry, Dr. Xu developed a moist exposed burn therapy. This innovative approach is based on Dr. Xu's understanding of the fundamental principle of life: life needs water to thrive and physiological regeneration will not sustain without water. Dr. Xu started his wound healing experiments with the skin of plants (e.g., pumpkins), then expanded to experimental animal models (e.g., rabbits and pigs), and finally humans (including Dr. Xu himself).
Having succeeded at all levels experimentally, Dr. Xu established an innovative therapeutic system for treating burn patients by integrating moist-exposed burns treatment (MEBT) with a proprietary product developed based on a unique combination and formulation of natural substances. With this treatment, Dr. Xu has been able to successfully regenerate healthy tissues on burn victims, and restore physiological structure and function of the skin and other tissues on the wounds, thereby dramatically reducing pain, morbidity and mortality.
Dr. Xu continued his exploration of regenerative medicine for the whole body. Through years of cellular, animal and clinical studies of tissue/organ regeneration by applying MEBO regenerative medicines and nutrients, Dr. Xu and his research team started to reveal the fundamental principles for regenerating adult organs. The intrinsic capability of human adults to regenerate cells can be harnessed to repair, renew and regenerate damaged or diseased tissues, as well as organs. This regeneration can take place in situ under the appropriate environmental conditions facilitated by extrinsic substances, such as MEBO regenerative medicines and nutrients. Based on the research and scientific achievement, Dr. Xu established a new scientific system named by Human Regenerative Restoration Science.
Articles about Dr. Rongxiang Xu
Veves Receives Xu Professorship at Harvard (Here)
Dr. Rongxiang Xu, Patent Owner of Damaged Organ Regeneration, A Top Priority Addressed in the 2013 Presidential State of The Union, Announces Plan of "Creating 10,000 Regenerative Humans" (Here)
Life Science Lab and Chair Endowed at USC Leonard Davis School of Gerontology (Here)
MEBO's Founder Dr. RongXiang Xu @ Cal State Los Angeles
Rongxiang Xu College of Health and Human Services
Dr. RongXiang Xu @ Harvard BIDMC
Rongxiang Xu, MD, Center for Regenerative Therapeutics
Rongxiang Xu, MD, Center for Regenerative Therapeutics
Dr. RongXiang Xu's National Foundation
MEBO's CEO Kevin Xu
Kevin Xu | CEO - MEBO International | Forbes Councils
Kevin Xu and APEC
APEC Economic Leaders Meeting Kicked Off
GI Regenerate @ Scientific Research Journal
https://www.scirp.org/journal/paperinformation.aspx?paperid=100342